Integrity Continuing Education
M

Expert Panel Case Discussion: BRCA+ Epithelial Ovarian Cancer Who Has Responded Well to Platinum-Based Chemo

By Integrity Continuing Education FEATURING Martina Murphy, Eleonora Teplinsky, Mollie Finkel
By Integrity Continuing Education FEATURING Martina Murphy, Eleonora Teplinsky, Mollie Finkel
76 views
January 24, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn

Featured Video

23:46
AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positiv…

Feat. S. Lewin

Related Content

AUTOPLAY
27:04
Fengting Yan

Cancer Screening Molecular Tools

17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
11:15
Total Health

2024 Updates in Ovarian Cancer

Feat. T. Tillmanns
06:50
Fengting Yan

Year in Review: Ovarian Cancer

25:10
Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner
15:14
Brian Slomovitz

Update in Vulvar and Vaginal Cancer

06:23
Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz
28:11
OncoAlert

Ovarian Cancer: Setting a New Standard of Care

Feat. M. Raza Mirza
05:20
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…

Feat. E. Buchbinder
18:16
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…

Feat. J. Kurtz
15:45
Michael Birrer

Defining Platinum Resistance in Ovarian Cancer

05:09
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo
05:32
Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi
23:35
Kathleen Moore

How to Select the Best Maintenance Treatment in Patients With Ovaria…

14:05
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comp…

Feat. A. Clamp
09:42
Erin Crane

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer

17:06
Ovarian Cancer Midwest Focus, University of Minnesota

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Feat. S. Lheureux
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

11:37
UCLA Health

Recurrent Cervical Cancer Updates

Feat. R. Salani